{"id":"W4309425609","doi":"10.1016/j.ahj.2022.11.015","title":"Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Blood transfusion and management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut Universitaire de Gériatrie de Montréal; Ottawa Hospital; University of Alberta; Canadian VIGOUR Centre; University of Toronto; St. Michael's Hospital","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Esperion Therapeutics; GlaxoSmithKline; HLS Therapeutics; Daiichi Sankyo Europe; Servier; University of Toronto; Agence Nationale de la Recherche; Novo Nordisk; Daiichi-Sankyo; Cerus Corporation; Canadian Blood Services; ReCor Medical; AstraZeneca; Amarin Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; Pfizer; York University; Bristol-Myers Squibb; Eli Lilly and Company; Institute of Circulatory and Respiratory Health; CSL Behring; Heart and Stroke Foundation of Canada; Sanofi; MicroPort; Amgen","keywords":"Medicine; Unstable angina; Myocardial infarction; Clinical trial; Randomized controlled trial; Hemoglobin; Angina; Internal medicine; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0787725,0.006853294,0.010749,0.003172481,0.002746904,0.006651864,0.004123046,0.008898767,0.03984646],"category_scores_gemma":[0.07384817,0.004969214,0.005635992,0.00296993,0.008384025,0.003162007,0.002130864,0.009678302,0.009797846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002651198,"about_ca_system_score_gemma":0.008245127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001352085,"about_ca_topic_score_gemma":0.001674591,"domain_scores_codex":[0.9272966,0.05319742,0.005210375,0.006935989,0.004660612,0.002699],"domain_scores_gemma":[0.9833156,0.008129465,0.002417518,0.003013035,0.001544147,0.001580204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7365943,0.007075763,0.00668442,0.02269361,0.01065619,0.001041671,0.001141393,0.005790271,0.00327655,0.08797197,0.05659164,0.06048221],"study_design_scores_gemma":[0.8481286,0.01806934,0.004986073,0.004259737,0.006005219,0.0005097952,0.0002736675,0.009753924,0.001360326,0.04701088,0.05927659,0.0003657793],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"empirical","genre_scores_codex":[0.02059642,0.009724692,0.04111633,0.009059993,0.007995626,0.8915645,0.01074205,0.0009304234,0.008269917],"genre_scores_gemma":[0.05471372,0.001323681,0.04690479,0.006604677,0.001250596,0.88429,0.00157219,0.0001074202,0.00323296],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0787725,"threshold_uncertainty_score":0.4165938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06176637577081637,"score_gpt":0.354774876570172,"score_spread":0.2930085007993557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}